Addis Ababa: The National Liberation Front (NLF) of Algeria has underscored the critical importance of stronger solidarity among African nations to tackle the pressing challenges of the continent. Abdelkrim Benmbarek, secretary-general of Algeria’s NL…
Month: February 2025
Russia Advocates for UN Reforms to Increase African and Latin American Representation
Moscow: Russia pursues consensus-based reform of the United Nations to better reflect the global landscape, particularly by increasing the representation of African and Latin American countries, Russian Federation Senator and Bureau Member of the Supr…
Kenya’s UDA Party Leader Stresses for Establishment Transcontinental Media
Addis Ababa: The United Democratic Alliance Party (UDA) Executive Director, Nicodemus Bore, has urged for the formation of transcontinental media to promote the true images of Africa and shape its own narrative. Bore highlighted the steadily growing c…
Ethiopia Reaffirms Commitment to Full Implementation of Ankara Declaration
Addis Ababa: Minister of Foreign Affairs, Gedion Timothewos, welcomed a high-level delegation led by the Deputy Minister of Foreign Affairs of the Republic of Trkiye, Burhanettin Duran. The two sides exchanged views on the upcoming technical negotiati…
Mastercard Aims to Strengthen Commitment to Uganda with New Office in Kampala
Kampala: Mastercard has announced the opening of its first office in Uganda, marking a significant milestone in its expansion across East Africa. This strategic move underscores Mastercard’s dedication to fostering financial inclusion and accelerating…
Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end 2025- – Enrollment of Phase […]